People: Align Technology Inc (ALGN.O)

ALGN.O on Nasdaq

56.83USD
19 Dec 2014
Price Change (% chg)

$0.73 (+1.30%)
Prev Close
$56.10
Open
$56.27
Day's High
$57.21
Day's Low
$55.89
Volume
734,745
Avg. Vol
747,614
52-wk High
$65.10
52-wk Low
$43.27

Search Stocks

Morrow, George 

Brief Biography

Mr. George J. Morrow is an Independent Director of Align Technology Inc., since February 2006. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He is a member of the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products, Safeway Inc., a food and drug retailer and was a member of the board of directors of Human Genome Sciences, Inc., a biopharmaceutical discovery and development company, from March 2011 until its acquisition in August 2012 by GlaxoSmithKline plc. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

C. Raymond Larkin

--

Thomas Prescott

5,933,260

David White

3,558,340

John Graham

3,084,990

Emory Wright

2,706,150

Roger George

1,512,600
As Of 30 Dec 2013
Search Stocks